Human immunodeficiency virus endocrinopathy

• Main Authors: Uma Sinha, Nilanjan Sengupta, Prasanta Mukhopadhyay, Keshab Sinha Roy
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2011-01-01
• Series: Indian Journal of Endocrinology and Metabolism
• Subjects: Antiretroviral therapy; endocrinopathy; human immunodeficiency virus; lipodystrophy; wasting
• Online Access: http://www.ijem.in/article.asp?issn=2230-8210;year=2011;volume=15;issue=4;spage=251;epage=260;aulast=Sinha

Human immunodeficiency virus (HIV) endocrinopathy encompasses a broad spectrum of disorders. Almost all the endocrine organs are virtually affected by HIV infection. HIV can directly alter glandular function. More commonly secondary endocrine dysfunction occurs due to opportunistic infections and neoplasms in immunocompromised state. The complex interaction between HIV infection and endocrine system may be manifested as subtle biochemical and hormonal perturbation to overt glandular failure. Antiretroviral therapy as well as other essential medications often result in adverse endocrinal consequences. Apart from adrenal insufficiency, hypogonadism, diabetes and bone loss, AIDS wasting syndrome and HIV lipodystrophy need special reference. Endocrinal evaluation should proceed as in other patients with suspected endocrine dysfunction. Available treatment options have been shown to improve quality of life and long-term mortality in AIDS patients.